These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 23581945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 4. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 5. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb 03; 22(135):41-3. PubMed ID: 23444501
    [Abstract] [Full Text] [Related]

  • 6. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Lenchus JD.
    Hosp Pract (1995); 2013 Feb 03; 41(1):49-60. PubMed ID: 23466967
    [Abstract] [Full Text] [Related]

  • 7. Dabigatran, bleeding, and the regulators.
    Moore TJ, Cohen MR, Mattison DR.
    BMJ; 2014 Jul 23; 349():g4517. PubMed ID: 25056265
    [No Abstract] [Full Text] [Related]

  • 8. The trouble with dabigatran.
    Charlton B, Redberg R.
    BMJ; 2014 Jul 23; 349():g4681. PubMed ID: 25055830
    [No Abstract] [Full Text] [Related]

  • 9. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A, Bailey C, Abdelhafiz AH.
    Age Ageing; 2012 Sep 23; 41(5):681-4. PubMed ID: 22378612
    [Abstract] [Full Text] [Related]

  • 10. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
    Getta B, Muller N, Motum P, Hsu D, Zebeljan D, Rosenfeld D.
    Br J Haematol; 2015 May 23; 169(4):603-4. PubMed ID: 25425051
    [No Abstract] [Full Text] [Related]

  • 11. Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
    Fanikos J.
    J Med Econ; 2013 Oct 23; 16(10):1190-2. PubMed ID: 23919663
    [No Abstract] [Full Text] [Related]

  • 12. Concerns over data in key dabigatran trial.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4747. PubMed ID: 25055831
    [No Abstract] [Full Text] [Related]

  • 13. Dabigatran "non-inferior" to warfarin, but only just.
    BMJ; 2013 Feb 27; 346():f1219. PubMed ID: 23447339
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 17. Avoiding adverse events with dabigatran by careful selection of eligible patients.
    Baker RI, Harper P, McLintock C.
    Med J Aust; 2012 Apr 16; 196(7):431-2. PubMed ID: 22509863
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dabigatran - neurosurgical anathema?
    Thomas PA, Schaerf NB, Rosenfeld JV.
    Med J Aust; 2013 Aug 19; 199(4):238-40. PubMed ID: 23984772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.